Allbiosyn Biotechnology Co., Ltd. is committed to the development and industrial application of core raw materials in the fields of Gene Sequencing, siRNA drugs, mRNA vaccines, In Vitro Diagnostics, Fluorescence and Chemiluminescence dyes.
The company has a number of technology platforms with proprietary intellectual property rights, such as nucleotide polyphosphate modification technology, nucleotide synthesis (enzyme catalysis, crystallization and purification technology), RNA cyclization modification, molecular block technology of siRNA drugs, selective delivery technology of siRNA drugs, Enzyme-catalyzed Oligo synthesis, and Liquid-phase Oligonucleotide synthesis technology.
Products and Services: dNTP, NTP, Modified NTP, Cap analogues, Phosphoramidite, Modified Nucleotides, Chemiluminescent Reagents, Fluorescent Dyes, Gene Sequencing Reagents, Biological Enzymes, Recombinant Proteins, CRO services, etc.
more >
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight January 2025
